Latest Healthcare It News

Page 9 of 129
PainChek appoints seasoned US medtech executive Karen Holzberger as CEO to spearhead growth following FDA clearance and major US contracts.
Ada Torres
Ada Torres
20 July 2026
OncoSil Medical has gained Saudi FDA approval for its OncoSil™ device, enabling full reimbursement and commercial access in Saudi Arabia, the Middle East's largest healthcare market.
Ada Torres
Ada Torres
20 July 2026
Marlin Global's portfolio delivered a 2.0% gross return in Q2 2026, driven by rebounds in ICON and semiconductor holdings, but lagged a strong US market rally led by AI and chip stocks.
Victor Sage
Victor Sage
20 July 2026
Barramundi’s portfolio returned a solid 3.8% gross gain in Q2 2026, driven by strong AI-related infrastructure plays and takeover interest in key holdings, despite sector volatility and profit downgrades in healthcare and logistics.
Claire Turing
Claire Turing
20 July 2026
Kingfish Limited outperformed the S&P/NZX50G with an 8.7% gross portfolio return in Q2 2026, driven by strong results from Fisher & Paykel Healthcare, Vista Group, and Infratil, while a2 Milk faced supply chain and regulatory challenges.
Victor Sage
Victor Sage
20 July 2026
Microba Life Sciences has delivered robust FY26 growth in its core microbiome testing business, with revenues up 92% year-on-year and a new GI Navigator product set for launch in September 2026. The company also announced a $7 million annualised cost reduction program as it advances towards cashflow break-even.
Ada Torres
Ada Torres
16 July 2026
Australian Ethical reached a new record of $14.5 billion funds under management at June 30, 2026, driven by strong superannuation inflows and strategic investments amid challenging market conditions.
Claire Turing
Claire Turing
16 July 2026
Cyclopharm has landed a major US expansion deal with University Hospitals Cleveland, deploying Technegas® across 11 sites simultaneously and boosting its recurring revenue base in the Midwest.
Ada Torres
Ada Torres
15 July 2026
Mesoblast has completed treatment of 300 patients in its pivotal Phase 3 trial for rexlemestrocel-L, targeting chronic low back pain due to degenerative disc disease, with topline results expected mid-2027.
Ada Torres
Ada Torres
14 July 2026
HeraMED's Phase 1 pilot with Lee Health confirms strong patient adoption and operational efficiency for its digital maternity care platform, setting the stage for broader US rollout.
Ada Torres
Ada Torres
14 July 2026
Ryman Healthcare reported steady retirement living sales in Q1 FY27 with a 7% rise in net resales, buoyed by serviced apartments. The company remains on track for FY27 build targets and sees robust aged care occupancy despite housing market headwinds.
Ada Torres
Ada Torres
14 July 2026
Visionflex Group turned the corner with positive operating cash flow in Q4 FY26 and the launch of its unattended access capability, while securing new contracts to expand its virtual healthcare footprint.
Victor Sage
Victor Sage
13 July 2026

Browse the archive

Full archive